The Food and Drugs Authority (FDA) of Ghana has defended its decision to extend the “best-before” date for 22,000 bags of rice distributed to Senior High Schools (SHSs) across the country, asserting that the rice was confirmed to be safe and wholesome following a series of quality assessments.
This clarification comes in response to allegations by North Tongu MP Samuel Okudzeto Ablakwa, who claimed the rice, initially marked to expire in December 2023, was unwholesome and repackaged with misleading labels. Ablakwa further accused the National Food Buffer Stock Company (NAFCO) and Lamens Investments Africa Limited of distributing expired rice.
Key Details:
- Quality Assessment: The FDA conducted tests alongside the Centre for Scientific and Industrial Research (CSIR) and an accredited Indian laboratory, confirming the rice met quality standards.
- Extension Decision: Based on the findings, the FDA extended the rice’s “best-before” date to April 2024, instead of the December 2024 extension initially requested by the company.
- Penalty for Noncompliance: Lamens Investments Africa Limited was fined GH¢100,000 for repackaging the rice without prior FDA approval.
- Further Scrutiny: The FDA also demanded additional evidence from the manufacturer before considering further extensions beyond April 2024.
Joseph Yaw-Bernie Bennie, Director of Legal and Corporate Affairs for the FDA, emphasized that the extension was based on rigorous scientific evaluations, ensuring the rice remained safe for consumption during the extended period.
The controversy highlights ongoing concerns about food safety and transparency in the distribution of essential supplies to public institutions.
